Table 4.
Method of delivery | Advantages | Disadvantages |
---|---|---|
Intra-cerebroventricular | Directly in the brain; Distribute in all brain | Difficult to apply in clinic; Dilution of the siRNA and potential degradation; Off target effects on other brain regions |
Intra-vascular, tail vein and carotid | Possible in clinic | Difficulties to cross BBB; Off target effects on other organs (i.e., Liver); Dilution of the siRNA; Increase chance of siRNA degradation |
In the brain structures: Cortex and hippocampus | In the targeted brain region; Small amount of siRNA | Difficult to apply in clinic; Mechanical lesion by the injection; Neuroinflammation |
Intra-nasal | Target the brain; Diffusion along the perivascular space; Possible in clinic; Accommodate large molecules |
Potential dilution of siRNA and degradation; Off target effects on lungs and other brain regions |